Home › NDC Lookup › RxCUI directory › RxCUI 1539243

Dalbavancin 500 MG Injection — RxCUI 1539243

Name: Dalbavancin 500 MG Injection (RxCUI 1539243)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1539243 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1539243

Official nameDalbavancin 500 MG Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asdalbavancin (as dalbavancin hydrochloride) 500 MG Injection

FDA products mapped6

Package NDCs mapped6

Reported Medicaid activity (SDUD)5,497 prescriptions · 39 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dalbavancin Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Yes, dalbavancin (Dalvance) is specifically approved for serious bacterial skin infections — what doctors call acute bacterial skin and skin structure infections, or ABSSSI. These...
What kind of infection does this treat — is it just for skin infections?
That's the unique thing about dalbavancin — it has an unusually long half-life of about 8.5 days, meaning it stays active in your body at effective levels for well over a week afte...
Why do I only need one IV infusion? Antibiotics usually take days or weeks.

📖 Read our full Dalbavancin Injection guide →

🕸️ Concept Web — How Dalbavancin 500 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Dalbavancin 500 MG Injection RxCUI 1539243 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Dalbavancin 1539239 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Dalvance 1539244 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Dalbavancin Injection 1806675 SCDF
- Dalbavancin Injectable Product 1539241 SCDG
- Dalbavancin Injection [Dalvance] 1806678 SBDF
- Dalvance Injectable Product 1539247 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Dalbavancin 500 MG 1806674 SCDC
- Dalbavancin 500 MG Injection [Dalvance] 1539248 SBD
- Dalbavancin 500 MG [Dalvance] 1806677 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Dalbavancin 500 MG SCDC · 1806674
Dalbavancin Injection SCDF · 1806675
Dalbavancin Injectable Product SCDG · 1539241

Brand-Name Concepts

Dalbavancin 500 MG Injection [Dalvance] SBD · 1539248
Dalbavancin 500 MG [Dalvance] SBDC · 1806677
Dalbavancin Injection [Dalvance] SBDF · 1806678
Dalvance Injectable Product SBDG · 1539247
Dalvance BN · 1539244

📦 FDA Products & Package NDCs

6 products · 6 package NDCs

6 package NDCs map to RxCUI 1539243 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00480-3325-01	1 VIAL in 1 CARTON (0480-3325-01) / 25 mL in 1 VIAL	Dalbavancin	Teva Pharmaceuticals, Inc.	2025-10-29
57970-0100-01	1 VIAL in 1 PACKAGE (57970-100-01) / 25 mL in 1 VIAL	DALVANCE	Allergan, Inc.	2014-05-23
65219-0120-12	1 VIAL in 1 PACKAGE (65219-120-12) / 25 mL in 1 VIAL	DALBAVANCIN HYDROCHLORIDE	Fresenius Kabi USA, LLC	2025-11-10
71288-0034-50	1 VIAL, SINGLE-DOSE in 1 CARTON (71288-034-50) / 25 mL in 1...	Dalbavancin	Meitheal Pharmaceuticals Inc	2025-11-26
71839-0144-01	1 VIAL in 1 CARTON (71839-144-01) / 25 mL in 1 VIAL	Dalbavancin	BE Pharmaceuticals Inc.	2026-06-12
81298-2390-01	1 VIAL in 1 CARTON (81298-2390-1) / 1 INJECTION, POWDER, FO...	Dalbavancin	Long Grove Pharmaceuticals, LLC	2026-03-03

Observed labelers: Allergan, Inc. (1) · BE Pharmaceuticals Inc. (1) · Fresenius Kabi USA, LLC (1) · Long Grove Pharmaceuticals, LLC (1) · Meitheal Pharmaceuticals Inc (1) · Teva Pharmaceuticals, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J0875	Injection, dalbavancin	5	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.